19018-Lung Cancer-NA-524

Lung Cancer

516-005: A Randomized Phase 3 Study of Sitravatinib in Combination with Nivolumab Versus Docetaxel in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with Disease Progression On or After Platinum-Based Chemotherapy in Combination with Checkpoint Inhibitor Therapy

  • Details

ClinicalTrials.gov ID: NCT03906071
Diagnosis Type: NA
USOR Number: 19018

  • Address

2800 Highway 75 North
Sherman, TX 75090
P: (903) 868-4700

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.